FI943738A - Hydroksyyliamiineista johdetut N,N'-substituoidut imidokarbonimidi-diamidit - Google Patents

Hydroksyyliamiineista johdetut N,N'-substituoidut imidokarbonimidi-diamidit Download PDF

Info

Publication number
FI943738A
FI943738A FI943738A FI943738A FI943738A FI 943738 A FI943738 A FI 943738A FI 943738 A FI943738 A FI 943738A FI 943738 A FI943738 A FI 943738A FI 943738 A FI943738 A FI 943738A
Authority
FI
Finland
Prior art keywords
group
carbon atoms
mono
substituted
salts
Prior art date
Application number
FI943738A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI943738A0 (fi
Inventor
Craig Canfield
David P Jacobus
Neil J Lewis
Original Assignee
Jacobus Pharmaceutical Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jacobus Pharmaceutical Company filed Critical Jacobus Pharmaceutical Company
Publication of FI943738A0 publication Critical patent/FI943738A0/fi
Publication of FI943738A publication Critical patent/FI943738A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24Y being a hetero atom
    • C07C279/26X and Y being nitrogen atoms, i.e. biguanides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/11Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/13Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated and containing rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Paints Or Removers (AREA)
  • Seasonings (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Luminescent Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
FI943738A 1992-02-14 1994-08-12 Hydroksyyliamiineista johdetut N,N'-substituoidut imidokarbonimidi-diamidit FI943738A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/837,258 US5322858A (en) 1992-02-14 1992-02-14 N,N'-substituted imidodicarbonimidic diamides derived from hydroxylamines
PCT/US1993/000395 WO1993016037A1 (en) 1992-02-14 1993-01-19 N,n'-substituted imidocarbonimidic diamides derived from hydroxylamines

Publications (2)

Publication Number Publication Date
FI943738A0 FI943738A0 (fi) 1994-08-12
FI943738A true FI943738A (fi) 1994-10-12

Family

ID=25273975

Family Applications (1)

Application Number Title Priority Date Filing Date
FI943738A FI943738A (fi) 1992-02-14 1994-08-12 Hydroksyyliamiineista johdetut N,N'-substituoidut imidokarbonimidi-diamidit

Country Status (25)

Country Link
US (1) US5322858A (pl)
EP (1) EP0625967B1 (pl)
JP (1) JP3207200B2 (pl)
KR (1) KR950700243A (pl)
CN (1) CN1057520C (pl)
AT (1) ATE157352T1 (pl)
AU (1) AU668709B2 (pl)
CA (1) CA2129430C (pl)
CZ (1) CZ294257B6 (pl)
DE (1) DE69313438T2 (pl)
DK (1) DK0625967T3 (pl)
EG (1) EG20476A (pl)
ES (1) ES2108862T3 (pl)
FI (1) FI943738A (pl)
GR (1) GR3025429T3 (pl)
HU (1) HU220389B (pl)
IL (1) IL104484A (pl)
MX (1) MX9300688A (pl)
NO (1) NO302616B1 (pl)
NZ (1) NZ245865A (pl)
OA (1) OA10094A (pl)
PL (2) PL172001B1 (pl)
RU (1) RU2133737C1 (pl)
WO (1) WO1993016037A1 (pl)
ZA (1) ZA93974B (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4321444A1 (de) * 1993-06-28 1995-01-05 Bernd Prof Dr Clement Pharmazeutische Zubereitung
US6551614B2 (en) 2001-03-14 2003-04-22 Jacobus Pharmaceutical Co., Inc. Antimalarial N,N′-substituted biguanides derived from hydroxylamines
US7794965B2 (en) 2002-03-13 2010-09-14 Signum Biosciences, Inc. Method of identifying modulators of PP2A methylase
US7256218B2 (en) * 2002-11-22 2007-08-14 Jacobus Pharmaceutical Company, Inc. Biguanide and dihydrotriazine derivatives
CN1738794B (zh) * 2002-11-22 2010-12-22 雅各布斯制药公司 双胍和二氢三嗪衍生物
US8221804B2 (en) * 2005-02-03 2012-07-17 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
US7923041B2 (en) 2005-02-03 2011-04-12 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
AU2008310898B2 (en) 2007-10-08 2014-05-08 National Science and Technology Development Agency acting through National Center for Genetic Engineering and Biotechnology Antimalarial compounds with flexible side-chains
AU2008310767A1 (en) * 2007-10-13 2009-04-16 Cornell University Compositions for eliciting an immune response against mycobacterium avium subspecies paratuberculosis
AU2009239430B2 (en) 2008-04-21 2015-01-22 Signum Biosciences, Inc. Compounds, compositions and methods for making the same
AU2009244819A1 (en) * 2008-05-09 2009-11-12 Tolmar, Inc. Proguanil to treat skin/mucosal diseases
WO2016201288A1 (en) 2015-06-12 2016-12-15 Brown University Novel antibacterial compounds and methods of making and using same
US11261157B2 (en) 2016-12-08 2022-03-01 Novatarg, Inc. Fused bicyclic alkylene linked imidodicarbonimidic diamides, methods for synthesis, and uses in therapy
US11555010B2 (en) 2019-07-25 2023-01-17 Brown University Diamide antimicrobial agents

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB603070A (en) * 1946-01-25 1948-06-08 Albert Frederick Crowther Manufacture of biguanide derivatives
GB665680A (en) * 1948-02-20 1952-01-30 Rhone Poulenc Sa Improvements in or relating to the production of n-p-chlorophenyl-n-isopropyl biguanide
DE824942C (de) * 1949-01-31 1951-12-17 Ici Ltd Verfahren zur Herstellung von Biguanidderivaten
GB667116A (en) * 1949-04-25 1952-02-27 Albert Frederick Crowther Manufacture of biguanide derivatives
GB814563A (en) * 1956-11-15 1959-06-10 Vitamins Ltd Biguanides
GB1270831A (en) * 1968-11-22 1972-04-19 Beecham Group Ltd Di-hydro triazine derivatives and processes for their manufacture
GB1250531A (pl) * 1969-01-01 1971-10-20
US3723429A (en) * 1969-11-06 1973-03-27 Beecham Group Ltd Di-hydro triazine derivatives
US3660394A (en) * 1970-01-23 1972-05-02 Vitamins Ltd 4 6-dibenzo-1 2-dihydro-aryloxy-1 3 5-triazines

Also Published As

Publication number Publication date
RU94039539A (ru) 1997-05-27
NZ245865A (en) 1996-02-27
OA10094A (en) 1996-12-18
CA2129430C (en) 2004-04-06
AU3475993A (en) 1993-09-03
ZA93974B (en) 1993-09-14
FI943738A0 (fi) 1994-08-12
EP0625967B1 (en) 1997-08-27
PL172001B1 (pl) 1997-07-31
CN1057520C (zh) 2000-10-18
NO302616B1 (no) 1998-03-30
ATE157352T1 (de) 1997-09-15
NO942988L (no) 1994-10-05
CA2129430A1 (en) 1993-08-15
EG20476A (en) 1999-05-31
JP3207200B2 (ja) 2001-09-10
NO942988D0 (no) 1994-08-12
WO1993016037A1 (en) 1993-08-19
PL173258B1 (pl) 1998-02-27
AU668709B2 (en) 1996-05-16
IL104484A0 (en) 1993-05-13
CZ294257B6 (cs) 2004-11-10
CZ196494A3 (en) 1995-10-18
HUT68802A (en) 1995-07-28
DK0625967T3 (da) 1998-03-23
ES2108862T3 (es) 1998-01-01
IL104484A (en) 1998-07-15
MX9300688A (es) 1993-08-01
GR3025429T3 (en) 1998-02-27
US5322858A (en) 1994-06-21
DE69313438D1 (de) 1997-10-02
HU9401976D0 (en) 1994-09-28
KR950700243A (ko) 1995-01-16
CN1076689A (zh) 1993-09-29
RU2133737C1 (ru) 1999-07-27
DE69313438T2 (de) 1998-03-19
HU220389B (hu) 2002-01-28
JPH07503730A (ja) 1995-04-20
EP0625967A1 (en) 1994-11-30

Similar Documents

Publication Publication Date Title
FI943738A (fi) Hydroksyyliamiineista johdetut N,N'-substituoidut imidokarbonimidi-diamidit
DK0602454T3 (da) N-oxycarbonylsubstituerede 5-deoxy-5-fluorcytidiner
JPS6447749A (en) Desferrioxamine compound
MY110821A (en) Oxidation inhibited arylcyclobutene polymers
DK0870765T3 (da) Aminothiazolderivat, lægemiddel indeholdende samme og mellemprodukt til fremstilling af forbindelsen
DE69918404D1 (de) Aminophenoxyessigsäure derivate als neuroschützende mittel
CA2528122A1 (en) Trans-1,2-cyclohexane bis[urea-urethane] compounds
PT1280809E (pt) Derivados antitumorais de ecteinascidina
TR200100603T2 (tr) Pirazin bileşikleri
DK0548338T3 (da) Fremgangsmåde til fremstilling af cephalosporinmellemprodukter
DK0485219T3 (da) Lægemidler til forebyggelse og behandling af kredsløbsorgansygdomme indeholdende spiro-3-heteroazolidinforbindelser
PT1021405E (pt) Derivados de azetidinona para o tratamento de infeccoes de hcmv
HUP0500557A2 (hu) Tiazolszármazékok alkalmazása mitokondriumok védelmére szolgáló gyógyszer előállítására
DK0504807T3 (da) Anvendelse af bis(p-hydroxyphenylthio)methanderivater til inhibering af progressiv udvikling af insulinafhængig diabetes mellitus
CA2036643A1 (en) Sulfur-containing esters as synergists of amine and phenolic antioxidants
ES2077697T3 (es) Derivados de 1-fenoxicarbonil-2-pirrolidinona y agentes nootropicos.